Frontlight ResearchEarly access
WithdrawnNo phase
Screening for Obstructive Sleep Apnea in Medical Patients
Key facts
- Who runs it
- Jordan Collaborating Cardiology Group
- Where
- Jordan2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 15 Oct 2023
- Ended
- 22 Feb 2025
- Type of study
- Observational
- Treatments tested
- Screening for obstructive sleep apnea
- Record updated
- 25 February 2025
- Why it stopped
- no patients found
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Willing to sign an informed consent
- Patient is admitted to the medical ward in a tertiary hospital
Who cannot take part
- Patients younger than 18 years of age
- Patients known to have obstructive sleep apnea
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences.
Read full original descriptionShow less
Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.
Treatments tested
- Screening for obstructive sleep apnea
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Screening for Obstructive Sleep Apnea in the General Medical Ward in Tertiary Care Centers in the Middle East
- Record updated
- 25 February 2025